Ditchcarbon
  • Customers
  1. Organizations
  2. Mesoblast Limited
Public Profile
Pharmaceutical Preparation Manufacturing
AU
updated 5 months ago

Mesoblast Limited

Company website

Mesoblast Limited, an innovative leader in regenerative medicine, is headquartered in Australia and operates extensively across North America, Europe, and Asia. Founded in 2004, the company has made significant strides in developing advanced cell-based therapies, particularly in the fields of orthopaedics, cardiovascular diseases, and inflammatory conditions. Mesoblast's core products, including its proprietary allogeneic cell therapy platforms, are designed to address unmet medical needs with unique mechanisms of action that promote healing and tissue regeneration. The company has achieved notable milestones, including successful clinical trials and partnerships that enhance its market position in the biotechnology sector. With a commitment to transforming patient care, Mesoblast continues to be at the forefront of innovation in regenerative medicine.

DitchCarbon Score

How does Mesoblast Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

16

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Mesoblast Limited's score of 16 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.

9%

Let us know if this data was useful to you

Mesoblast Limited's reported carbon emissions

Mesoblast Limited, headquartered in Australia, currently does not report any specific carbon emissions data, as there are no available figures for kg CO2e emissions. Additionally, the company has not established any documented reduction targets or climate pledges. As of now, Mesoblast Limited does not inherit emissions data from any parent or related organizations, indicating that their climate commitments and emissions reporting are independent. Without specific emissions data or reduction initiatives, it is unclear how the company is addressing climate change within its operations. In the absence of concrete figures or commitments, stakeholders may look forward to future disclosures that could outline Mesoblast's approach to sustainability and carbon management.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Mesoblast Limited's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Mesoblast Limited is in AU, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Mesoblast Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Predictive Technology Group, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

BioRestorative Therapies, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Lineage Cell Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Compugen Ltd.

IL
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

IntelliCell BioSciences, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Liveyon LLC.

US
•
Research and development services (73)
Updated 14 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy